• 60% of KSA and UAE companies expressed increasing concern about data protection and data privacy compliance
• 51% of KSA and UAE companies expressed increasing concern about cyber breaches and insider threats
• 67% of respondents from the KSA and UAE believe that the utilization of FDA has been effective towards increased data protection and data privacy compliance
• 100% of respondents across the KSA and UAE who use FDA towards regulatory compliance agree that it has been effective
• 85% of respondents from the KSA and UAE believe the use of FDA helps towards performing improved risk assessments
o A further 58% use FDA to ensure they meet regulatory expectations, as opposed to 79% globally
• Over 70% of respondents indicated that they planning to adopt risk scoring and aggregation techniques
o They are likely turning to these and other FDA techniques such as user behavioral analytics and social medial analytics for continuous monitoring
• In KSA and UAE, robotic process automation is significantly ahead at 53% comparing with the global average of 39%
• A majority of organizations in the KSA and UAE use employee and customer data to analyze areas of risk
o 83% of KSA and UAE companies use the structured FDA data source of customer relationship management to analyze the areas of risk that will impact their organizations
o 73% of KSA and UAE companies use the unstructured FDA data source of electronic communication to analyze the areas of risk that impact their organization
o 60% of KSA and UAE companies use the unstructured FDA data source of customer calls or meeting notes and 45% use social media to analyze the areas of risk that impact their organization
o Post GDPR, they will need to be aware of how they can continue using such data resources while remaining compliant
• In the KSA and UAE, 43% of respondents believe that management awareness of the benefits of FDA in managing risks needs to be improved
• 82% of respondents in the KSA and UAE are not ready for GDPR (effective in May 2018)
• 66% of respondents in the KSA and UAE are unaware of what tools they can use to stay compliant with GDPR
• The majority of respondents from the KSA and UAE believe that they realized the benefits of FDA through investments in experts in the profession, investment in the right FDA technology, or a strong tone from their respective leadership, promoting its use

© Press Release 2018